|
To ensure you receive F1000 emails, add
info@updates.f1000.com
to your safelist.
If this email is not displaying properly, please
view in your usual browser.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 2015
|
|
|
|
|
|
Save articles whilst you browse with just one click!
|
Importing references from the web shouldn't be hard - and now it isn't. Our new collaborative writing platform, F1000Workspace, has a nifty browser extension that allows you to instantly capture articles as you're surfing the web, with just a click of a button. You can even make notes on the article itself.
Try it out for yourself, and read more on about our one-click browser extension on our blog.
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
Below is a selection of recommendations added by our Faculty of 10,000+ Members over the past month:
|
|
|
|
7
★
|
|
Birdy see, birdy do
|
|
|
Cultural conformity isn't just a trait in humans - this study provides the first experimental demonstration that this also occurs in wild birds.
Aplin LM, Farine DR, Morand-Ferron J et al.
Nature. 2015; 518:538-41
|
|
|
|
6
★
|
|
Fat lot of good
|
|
|
Defective fatty acid oxidation in renal tubal epithelial cells plays a key role in kidney fibrosis development and chronic kidney disease.
Kang HM, Ahn SH, Choi P
et al.
Nat Med.
2015 Jan; 21:37-46
|
|
|
|
10
★
|
|
Liberal or conservative?
|
|
|
This investigation is an important piece in the 'chess battle' between liberal vs. restrictive transfusion policies after cardiac surgery.
Murphy GJ, Pike K, Rogers CA
et al.
N Engl J Med.
2015; 372:997-1008
|
|
|
|
F1000Prime Reports
|
|
|
|
The F1000Prime Reports journal has
migrated! The open-access journal will now be published on our F1000Research platform, on the
Faculty Reviews channel. Find out more
on our blog.
|
|
|
|
 |
|
|
Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction
Cystic fibrosis is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The recent licensing of the first drug targeting the molecular defect in the CFTR protein found in ~5% of cystic fibrosis patients may herald a new era with tailored therapies for cystic fibrosis with other CFTR mutations.
F1000Prime Report
by Griesenbach U, Alton EWFW.
F1000Prime Rep
2015,
7:64
See all recent articles on the Faculty Reviews Channel.
|
|
|
|
|
|
|
|
|
|
|
Our innovative
open science publishing platform
offering rapid publication, open peer review and open data. Below is a selection of our latest peer reviewed articles:
|
|
|
RESEARCH ARTICLE
A reanalysis of mouse ENCODE comparative gene expression data [v1; ref status: approved with reservations 1,
http://f1000r.es/5ez]
Published: 19 May 2015
Gilad Y, Mizrahi-Man O
F1000Research
2015, 4:121 |
|
|
RESEARCH ARTICLE
Short-term effect of acute and repeated urinary bladder inflammation on thigmotactic behaviour in the laboratory rat
[v1; ref status: indexed,
http://f1000r.es/56e]
Published: 08 May 2015
Morland RH, Novejarque A, Huang W et al.
F1000Research
2015, 4:109 |
|
|
RESEARCH ARTICLE
The Resource Identification Initiative: A cultural shift in publishing
[v1; ref status: approved 1,
http://f1000r.es/5fj]
Published: 29 May 2015
Bandrowski A, Brush M, Grethe JS
et al.
F1000Research
2015, 4:134 |
|
|
RESEARCH ARTICLE
Promiscuity progression of bioactive compounds over time
[v1; ref status: indexed,
http://f1000r.es/5cx]
Published: 13 May 2015
Hu Y, Jasial S, Bajorath J.
F1000Research
2015,
4(Chem Inf Sci):118
|
|
|
|
|
|
| Five deadly sins of science publishing |
|
|
| F1000 Chairman Vitek Tracz gave a seminar at Collège de France in April titled, "The five deadly sins of science publishing". Watch it on YouTube, and read the accompanying editorial.
|
|
|
| Antibody Validation channel |
|
|
| F1000Research's Antibody Validation article channel provides a platform for researchers and companies to validate antibodies, share results and receive credit for important experimental work. Thanks to financial support from NOVUS and R&D SYSTEMS, all studies in the channel will be published free of charge throughout 2015.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Open Repository
for posters and slide presentations; completely free to view and submit. Below is a selection:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Citing peer review activities |
|
|
|
|
|
ORCID and F1000 have partnered to develop a practical means for citing peer review activities. Enabling referees to cite their referee reports and include them on ORCID records is a major step in recognizing an activity fundamental for scientific advancement. Read more.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
You have received this message because you asked to receive the F1000 Monthly Update to your registered email address from Faculty of 1000. If you do not wish to receive any further such messages, you may
unsubscribe
at any time.
For further information or enquiries please contact Customer Services at
info@f1000.com
.
Faculty of 1000 Ltd | Science Navigation Group
Registered in England and Wales with Company Number 3739756
Middlesex House, 34-42 Cleveland Street | London, W1T 4LB | United Kingdom
|
|
|
